Semler Scientific Inc(SMLR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 7.31 | EPS (ttm) | 2.78 | Insider Own | 0.02% | Shs Outstand | 15.3M | Perf Week | -1.64% |
| Market Cap | 0.31B | Forward P/E | - | EPS next Y | - | Insider Trans | -97% | Shs Float | 15.3M | Perf Month | 26.82% |
| Enterprise Value | 0.32B | PEG | - | EPS next Q | - | Inst Own | 65.71% | Short Float | 17.89% | Perf Quarter | -20.18% |
| Income | 0.05B | P/S | 8.41 | EPS this Y | - | Inst Trans | -0.31% | Short Ratio | 4.05 | Perf Half Y | -53.37% |
| Sales | 0.04B | P/B | 0.67 | EPS next 5Y | - | ROA | 14.03% | Short Interest | 2.73M | Perf YTD | 32.96% |
| Book/sh | 30.36 | P/C | 29.38 | EPS past 3/5Y | 34.29% 22.23% | ROE | 17.74% | 52W High | -69.43% ($66.50) | Perf Year | -62.99% |
| Cash/sh | 0.69 | P/FCF | - | Sales past 3/5Y | 2.01% 11.43% | ROIC | 10.51% | 52W Low | 36.58% ($14.89) | Perf 3Y | -46.6% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 62.6% | Gross Margin | 90.76% | Volatility(W/M) | 14.62% 9.95% | Perf 5Y | -77.15% |
| Dividend TTM | - | EV/Sales | 8.67 | Sales Y/Y TTM | -37.29% | Oper. Margin | -14.21% | ATR (14) | 2.07 | Perf 10Y | 484.21% |
| Dividend Ex-Date | - | Quick Ratio | 1.95 | EPS Q/Q | 48.89% | Profit Margin | 130.8% | RSI (14) | 52.28 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.97 | Sales Q/Q | -44.56% | SMA20 | 9.42% ($18.58) | Beta | 1.33 | Target Price | $51 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2025/11/06 | SMA50 | -0.25% ($20.38) | Rel Volume | 0 | Prev Close | $20.33 |
| Employees | 79 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 2390.91% -2.19% | SMA200 | -33% ($30.34) | Avg Volume(3M) | 0.67M | Price | $20.33 |
| IPO | 2014/2/21 | Option/Short | No/No | Trades | 0 | Volume | - | Change | - |
🩺 Semler Scientific (SMLR) is a healthcare technology company that develops and sells innovative diagnostic medical device software for measuring arterial blood flow to support healthcare providers in evaluating and treating patients with chronic diseases.
Over the past 1 year, on the lower side
69% below its 1-year high.
Traded less than usual. That is 0% of its average volume.
SMLR has a sound balance sheet but weak earning power
Of every $100 in sales, $14.21 is lost.
Tap to view numbers
Within its industry, it looks cheap
For a company earning $100 a year, you would pay $731. Peers typically go for $1,970.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -77.2%. The S&P 500 did +61% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 65.7%.
Tap to view numbers
It ranks #69 of 141 in the industry
Based on market cap of $311M.
OFIX#67 Orthofix Medical Inc $322M PER - 
TMCI#68 Treace Medical Concepts Inc $311M PER - SMLR#69 Semler Scientific Inc $311M PER 7.3 
QSI#69 Quantum-Si Incorporated $300M PER - 
CLPT#70 ClearPoint Neuro Inc $293M PER - 
FAQ
What kind of company is SMLR?
SMLR belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of SMLR?
The market cap of SMLR is approximately $311M, ranking 3,640 within its sector.
What is the P/E ratio of SMLR?
SMLR has a P/E ratio of approximately 7.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for SMLR?
SMLR has recorded a 52-week high of $66.50 and a low of $14.89.
